EUVIMEDOpdag EUVIMED
Crossref

Injectable Decellularized Extracellular Matrix Hydrogel Containing Stromal Cell-Derived Factor 1 Promotes Transplanted Cardiomyocyte Engraftment and Functional Regeneration after Myocardial Infarction

Kui Wu, Yuanyuan Wang, Hong Yang, Yihuan Chen, Kunyan Lu, Yong Wu, Chunxia Liu, Haixin Zhang, Hanyu Meng, Qian Yu iD, Yanxia Zhang iD, Zhenya Shen

ACS Applied Materials & Interfaces · 2023

DOI: 10.1021/acsami.2c16682 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, 2023. Written by Kui Wu and 11 co-authors. Institution: Department of Cardiovascular Surgery of the First Affiliated Hospital and Institute for Cardiovascular Science, Suzhou Medical College of Soochow Uni…. Major MEDLINE topics: Chemokine CXCL12, Decellularized Extracellular Matrix, Hydrogels, Myocardial Infarction. Cited 65 times so far (Crossref); 52 references. Funded by: National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions, Jiangsu Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Transplantation of exogenous cardiomyocytes (CMs) is a hopeful method to treat myocardial infarction (MI). However, its clinical application still remains challenging due to low retention and survival rates of the transplanted cells. Herein, a stromal cell-derived factor 1 (SDF-1)-loaded injectable hydrogel based on a decellularized porcine extracellular matrix (dECM) is developed to encapsulate and deliver CMs locally to the infarct area of the heart. The soluble porcine cardiac dECM is composed of similar components such as the human cardiac ECM, which could be self-assembled into a nanofibrous hydrogel at physiological temperature to improve the retention of transplanted CMs. Furthermore, the chemokine SDF-1 could recruit endogenous cells to promote angiogenesis, mitigating the ischemic microenvironment and improving the survival of CMs. The results in vitro show that this composite hydrogel exhibits good biocompatibility, anti-apoptosis property, and chemotactic effects for mesenchymal stromal cells and endothelial cells through SDF-1-CXCR4 axis. Moreover, intramyocardial injection of this composite hydrogel to the infarcted area leads to the promotion of angiogenesis and inhibition of fibrosis, reducing the infarction size and improving the cardiac function. The combination of natural biomaterials, exogenous cells, and bioactive factors shows potential for MI treatment in the clinical application.

Subjects

MeSH terms (MEDLINE)

Chemokine CXCL12Decellularized Extracellular MatrixHydrogelsMyocardial InfarctionMyocytes, CardiacAnimalsHumansEndothelial CellsExtracellular MatrixRegenerationSwine

Author keywords

SDF-1angiogenesiscardiomyocytedecellularized matrix hydrogelmyocardial infarction

Substances

Chemokine CXCL12Decellularized Extracellular MatrixHydrogels

Authors and institutions

  • Department of Cardiovascular Surgery of the First Affiliated Hospital and Institute for Cardiovascular Science, Suzhou Medical College of Soochow University, Soochow University, Suzhou 215007, P. R. China.
  • Department of Cardiovascular Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, P. R. China.
  • State and Local Joint Engineering Laboratory for Novel Functional Polymeric Materials, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, P. R. China.

ORCID profiles: Qian Yu, Yanxia Zhang

Funding

  • National Natural Science Foundation of China
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • Jiangsu Province
  • Key Laboratory of Polymeric Materials Design and Synthesis for Biomedical Function, Soochow University
  • Natural Science Foundation of the Jiangsu Higher Education Institutions
  • Suzhou City

Cite

APA

Wu, K., Wang, Y., Yang, H., Chen, Y., Lu, K., Wu, Y., Liu, C., Zhang, H., Meng, H., Yu, Q., Zhang, Y., & Shen, Z. (2023). Injectable Decellularized Extracellular Matrix Hydrogel Containing Stromal Cell-Derived Factor 1 Promotes Transplanted Cardiomyocyte Engraftment and Functional Regeneration after Myocardial Infarction. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.2c16682

Vancouver

Wu K, Wang Y, Yang H, Chen Y, Lu K, Wu Y, et al. Injectable Decellularized Extracellular Matrix Hydrogel Containing Stromal Cell-Derived Factor 1 Promotes Transplanted Cardiomyocyte Engraftment and Functional Regeneration after Myocardial Infarction. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.2c16682

BibTeX
@article{Wu2023,
  author = {Wu, Kui and Wang, Yuanyuan and Yang, Hong and Chen, Yihuan and Lu, Kunyan and Wu, Yong and Liu, Chunxia and Zhang, Haixin and Meng, Hanyu and Yu, Qian and Zhang, Yanxia and Shen, Zhenya},
  title = {Injectable Decellularized Extracellular Matrix Hydrogel Containing Stromal Cell-Derived Factor 1 Promotes Transplanted Cardiomyocyte Engraftment and Functional Regeneration after Myocardial Infarction},
  journal = {ACS Applied Materials & Interfaces},
  year = {2023},
  doi = {10.1021/acsami.2c16682}
}
Start for free →